Opinion: Medicare Part D must evolve to help people fight cancer
Medicare Part D has changed little since 2006. It's time to modernize the program to help older Americans take advantage of new drugs that can extend the lives of people…
A new drug that cures, or at least delays, a deadly disease like cancer represents a huge advance — unless no one can afford it. Innovation without access is meaningless.
In the past five years, we have witnessed the emergence of revolutionary scientific innovations for treating cancer such as immunotherapies, targeted oral cancer medicines, gene therapies, and more. These new approaches are turning many daunting cancers into manageable conditions.
These new advances won’t realize their full potential, however, unless patients have
